Concert Pharma deal with Avanir could top $200M
Mass High Tech
By Lori Valigra Concert Pharmaceuticals Inc., a clinical stage biotech company based in Lexington, said today it has an exclusive license agreement with Avanir Pharmaceuticals that could bring in more than $200 million. The license gives Avanir …
Avanir Pharmaceuticals and Concert Pharmaceuticals Announce License Agreement …
Concert Nabs $200M Deal From Avanir to Make Psych Drugs
Concert Pharma snags $200M licensing pact with Avanir